|
|||||
|
|
Lacosamide cardiac safety: a thorough QT/QTc trial in healthy volunteers |
|
| Authors: | D. Kropeit M. Johnson W. Cawello G. D. Rudd R. Horstmann |
| Affiliation: | 1. AiCuris GmbH & Co. KG, Wuppertal, Germany;2. UCB Pharma, Raleigh, NC, USA;3. UCB Pharma, Monheim am Rhein, Germany;4. Consulting Early Development, Bonn, Germany |
| Abstract: | |
| Keywords: | Cardiac Lacosamide PR interval QT interval Safety |